6511 - 6520 of 8616 Results
Title
Year
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
-
OPENTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6123262Citation Count: 132
- Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder2019OPENTitle: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0073-1Best OA location URL: https://www.nature.com/articles/s41531-018-0073-1.pdfCitation Count: 29
- Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy2018RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
-
OPENTitle: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 5Start Page: 2109End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982Citation Count: 61
- OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's disease2024OPENTitle: OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 123Issue #:Start Page: 106070End Page: 106070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106070Best OA location URL: http://www.prd-journal.com/article/S1353802024000828/pdfCitation Count: 1
-
OPENTitle: Clinical and Neuropathological Features Associated With Loss of RAB39BJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 687End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27951Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27951Citation Count: 18
-
OPENTitle: Prefrontal Physiomarkers of Anxiety and Depression in Parkinson’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.748165Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.748165/pdfCitation Count: 20
- The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP12018OPENTitle: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00064Best OA location URL: https://pub.dzne.de/record/139819Citation Count: 37
-
OPENTitle: Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin SignalingJournal Name: Molecular CellPublisher: Elsevier BVVol: 68Issue #: 1Start Page: 233End Page: 246.e5Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2017.08.020Best OA location URL: http://www.cell.com/article/S1097276517306172/pdfCitation Count: 178